[96] Hernández-Chávez I, Torres-Tapia LW, Simá-Polanco P, Cedillo-Rivera R, Moo-Puc P,
Peraza-Sánchez SR. Antigiardial activity of Cupania dentata bark and its constituents.
Journal of Mexican Chemical Society. 2012; 56 (2):105–108.
[97] WHO. Global incidence and prevalence of selected curable sexually transmitted infec-
tions—2008 [Internet]. 2012. Available from: http://www.who.int/reproductivehealth/
publications/rtis/stisestimates/en/[Accessed: 2016-10-10][98] Secretaría de Salud. SUIVE/DGE/SALUD/Información Epidemiológica de Morbilidad,
Anuario 2011 (SUIVE/DGE/SALUD/ Epidemiológic Information on Morbility, Yearbook
2011). Versión Ejecutiva [Internet]. 2012. Available from: http://www.epidemiologia.
salud.gob.mx/doctos/infoepid/publicaciones/2012/ver_ejecutiva_2011.pdf [Accessed: 2016-
09-10]
[99] Carlton JM, Hirt RP, Silva JC, Delcher AL, Schatz M, Zhao Q, Wortman JR, et al. Draft
genome sequence of the sexually transmitted pathogenTrichomonas vaginalis. Science.
2007; 315 (5809):207–212.
[100] Cotch MF, Pastorek JG 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach
DA, et al.Trichomonas vaginalisassociated with low birth weight and preterm delivery.
The Vaginal Infections and Prematurity Study Group. Sexually Transmitted Diseases.
1997; 24 :353–360.
[101] Sorvillo F, Kerndt P.Trichomonas vaginalisand amplification of HIV-1 transmission.
Lancet. 1998; 351 :213–214.
[102] Boselli F, Chiossi G, Bortolamasi M, Gallinelli A. Prevalence and determinants of genital
shedding of herpes simplex virus among women attending Italian colposcopy clinics.
European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2005; 118 (1):86–90.
[103] Sena AC, Lensing S, Rompalo A, Taylor SN, Martin DH, Lopez LM, Lee JY, et al.
Chlamydia trachomatis, Mycoplasma genitalium, andTrichomonas vaginalisinfections
in men with nongonococcal urethritis: predictors and persistence after therapy. The
Journal of Infectious Diseases. 2012; 206 :357–365. DOI: 10.1093/infdis/jis356[104] Sutcliffe S, Neace C, Magnuson NS, Reeves R, Alderete JF. Trichomonosis, a common
curable STI, and prostate carcinogenesis - a proposed molecular mechanism. PLoS
Pathogens. 2012; 8 :e1002801. DOI: 10.1371/journal.ppat.1002801[105] Wendel KA, Workowski KA. Trichomoniasis: challenges to appropriate management.
Clinical Infectious Diseases. 2007; 44 Suppl. 3:S123–129.[106] Müller M, Lossick JG, Gorell TE. In vitro susceptibility ofTrichomonas vaginalisto metro-
nidazole and treatment outcome in vaginal trichomoniasis. Sexually Transmitted Dis-
eases. 1988; 15 :17e249.[107] Upcroft JA, Dunn LA, Wright JM, Benakli K, Upcroft P, Vanelle P. 5-Nitroimidazole drugs
effective against metronidazole-resistantTrichomonas vaginalisand Giardia duodenalis
spp. Antimicrobial Agents and Chemotherapy. 2006; 50 :344–347.90 Natural Remedies in the Fight Against Parasites